Virtus ETF Advisers’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,849
| Closed | -$73.4K | – | 453 |
|
|
2024
Q1 | $73.4K | Buy |
25,849
+3,719
| +17% | +$10.6K | 0.04% | 402 |
|
|
2023
Q4 | $326K | Buy |
22,130
+9,907
| +81% | +$146K | 0.21% | 210 |
|
|
2023
Q3 | $224K | Sell |
12,223
-1,583
| -11% | -$29K | 0.14% | 234 |
|
|
2023
Q2 | $298K | Buy |
13,806
+5,346
| +63% | +$115K | 0.18% | 207 |
|
|
2023
Q1 | $248K | Buy |
8,460
+153
| +2% | +$4.49K | 0.14% | 288 |
|
|
2022
Q4 | $307K | Buy |
+8,307
| New | +$307K | 0.16% | 255 |
|